Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Masimo Corp (MASI)

Masimo Corp (MASI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI)

Patient Monitoring Stocks Q3 Recap: Benchmarking Masimo (NASDAQ:MASI)

MASI : 137.40 (-0.68%)
HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.  

MASI : 137.40 (-0.68%)
Masimo (MASI) Stock Is Up, What You Need To Know

Masimo (MASI) Stock Is Up, What You Need To Know

MASI : 137.40 (-0.68%)
Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth

Announces Long-Range Targets Including 7% - 10% Revenue CAGR Through 2028 Highlights Clear Focus on Patient Outcomes, Technology Innovation and Commercial Execution

MASI : 137.40 (-0.68%)
1 Volatile Stock to Target This Week and 2 We Ignore

1 Volatile Stock to Target This Week and 2 We Ignore

CUBI : 73.50 (+0.71%)
MASI : 137.40 (-0.68%)
ALNT : 55.03 (-0.67%)
Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

Clover Health, GoodRx, Moderna, UFP Technologies, and Masimo Shares Are Soaring, What You Need To Know

UFPT : 217.82 (-0.74%)
GDRX : 2.71 (-3.90%)
MASI : 137.40 (-0.68%)
MRNA : 29.92 (+1.56%)
CLOV : 2.62 (-2.96%)
Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case

IRVINE, Calif. , Nov. 18, 2025 /PRNewswire/ -- A team from Knobbe Martens led medical device pioneer Masimo (NASDAQ: MASI) to a victory over Apple in a dispute involving Masimo's patented heart monitoring...

MASI : 137.40 (-0.68%)
2 Small-Cap Stocks to Target This Week and 1 That Underwhelm

2 Small-Cap Stocks to Target This Week and 1 That Underwhelm

BPOP : 122.58 (+1.25%)
LC : 19.07 (-4.17%)
MASI : 137.40 (-0.68%)
Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages

Masimo (NASDAQ: MASI) today issued the following statement in response to the jury verdict announced in the U.S. District Court for the Central District of California, which confirmed the validity...

MASI : 137.40 (-0.68%)
5 Insightful Analyst Questions From Masimo’s Q3 Earnings Call

5 Insightful Analyst Questions From Masimo’s Q3 Earnings Call

MASI : 137.40 (-0.68%)

Barchart Exclusives

The QQQ Is at Risk of a Christmas Crash, So Pay Attention to Bond Yields Right Now
It’s past time that stock market participants started paying attention to bonds. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar